Issue 2, 2012

SV119-gold nanocage conjugates: a new platform for targeting cancer cellsvia sigma-2 receptors

Abstract

We have functionalized the surface of gold nanocages with SV119, a synthetic small molecule specific to sigma-2 receptors, and then demonstrated the capability of this new class of conjugates for targeting cancer cells.

Graphical abstract: SV119-gold nanocage conjugates: a new platform for targeting cancer cellsvia sigma-2 receptors

Supplementary files

Article information

Article type
Communication
Submitted
08 Oct 2011
Accepted
27 Oct 2011
First published
24 Nov 2011

Nanoscale, 2012,4, 421-424

SV119-gold nanocage conjugates: a new platform for targeting cancer cellsvia sigma-2 receptors

Y. Wang, J. Xu, X. Xia, M. Yang, S. Vangveravong, J. Chen, R. H. Mach and Y. Xia, Nanoscale, 2012, 4, 421 DOI: 10.1039/C1NR11469G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements